Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

Vera Therapeutics (VERA) News Today

→ Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad)
Free VERA Stock Alerts
$41.39
-0.55 (-1.31%)
(As of 05/17/2024 08:54 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media
May 16, 2024 | americanbankingnews.com
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Recommendation of "Buy" from Analysts
May 16, 2024 | marketbeat.com
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Consensus Recommendation of "Buy" by Brokerages
Shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) have earned a consensus rating of "Buy" from the eight analysts that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and one has
May 13, 2024 | marketbeat.com
Vera Therapeutics (NASDAQ:VERA) Shares Down 1.9%
Vera Therapeutics (NASDAQ:VERA) Trading Down 1.9%
May 13, 2024 | americanbankingnews.com
FY2028 EPS Estimates for Vera Therapeutics, Inc. (NASDAQ:VERA) Lifted by Wedbush
May 13, 2024 | americanbankingnews.com
Vera Therapeutics, Inc. Forecasted to Earn Q2 2024 Earnings of ($0.57) Per Share (NASDAQ:VERA)
May 12, 2024 | americanbankingnews.com
Vera Therapeutics (NASDAQ:VERA) PT Raised to $68.00
May 10, 2024 | marketbeat.com
Vera Therapeutics (NASDAQ:VERA) Issues Earnings Results
Vera Therapeutics (NASDAQ:VERA - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.56) earnings per share for the quarter, missing analysts' consensus estimates of ($0.53) by ($0.03).
May 9, 2024 | markets.businessinsider.com
Buy Rating Affirmed for Vera Therapeutics Amid Promising Clinical Developments and Strong Financial Position
May 9, 2024 | investorplace.com
VERA Stock Earnings: Vera Therapeutics Misses EPS for Q1 2024
May 9, 2024 | msn.com
Vera Therapeutics GAAP EPS of -$0.56
May 9, 2024 | globenewswire.com
Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
May 7, 2024 | globenewswire.com
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 6, 2024 | finance.yahoo.com
Vera Therapeutics, Inc.'s (NASDAQ:VERA) high institutional ownership speaks for itself as stock continues to impress, up 5.0% over last week
May 2, 2024 | markets.businessinsider.com
Incyte’s Resilient Demand and Strong Financials Justify Buy Rating Despite Q1 Sales Dip
May 1, 2024 | marketbeat.com
Vera Therapeutics (NASDAQ:VERA) Trading 6.5% Higher
Vera Therapeutics (NASDAQ:VERA) Trading Up 6.5%
April 15, 2024 | marketbeat.com
Vera Therapeutics (NASDAQ:VERA) Shares Down 3% After Insider Selling
Vera Therapeutics (NASDAQ:VERA) Shares Down 3% Following Insider Selling
April 14, 2024 | investing.com
Vera Therapeutics executive sells over $228k in company stock
April 14, 2024 | marketbeat.com
Vanguard Group Inc. Raises Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA)
Vanguard Group Inc. raised its stake in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 9.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,574,390 shares of the company's stock after pu
April 13, 2024 | insidertrades.com
Insider Selling: Vera Therapeutics, Inc. (NASDAQ:VERA) SVP Sells 5,714 Shares of Stock
April 13, 2024 | fool.com
Could This Stock Be the Next Biotech Buyout?
April 12, 2024 | finance.yahoo.com
Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...
April 12, 2024 | marketbeat.com
Joseph R. Young Sells 5,714 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) Stock
Vera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) SVP Joseph R. Young sold 5,714 shares of the company's stock in a transaction dated Wednesday, April 10th. The stock was sold at an average price of $40.00, for a total value of $228,560.00. Following the sale, the senior vice president now owns 53,171 shares in the company, valued at approximately $2,126,840. The sale was disclosed in a filing with the SEC, which is available through the SEC website.
April 11, 2024 | msn.com
Biotech Stocks Heat As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
April 10, 2024 | marketbeat.com
Vera Therapeutics (NASDAQ:VERA) Stock Price Up 7.2%
Vera Therapeutics (NASDAQ:VERA) Stock Price Up 7.2%
April 10, 2024 | msn.com
Alpine Immune jumps on report of takeover interest
April 8, 2024 | marketbeat.com
Vera Therapeutics (NASDAQ:VERA) Shares Gap Down on Insider Selling
Vera Therapeutics (NASDAQ:VERA) Shares Gap Down Following Insider Selling
April 8, 2024 | insidertrades.com
Vera Therapeutics, Inc. (NASDAQ:VERA) CFO Sells $3,954,187.08 in Stock
April 7, 2024 | nasdaq.com
Commit To Buy Vera Therapeutics At $25, Earn 12.7% Annualized Using Options
April 6, 2024 | marketbeat.com
Sean Grant Sells 99,828 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) Stock
Vera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) CFO Sean Grant sold 99,828 shares of the business's stock in a transaction dated Wednesday, April 3rd. The shares were sold at an average price of $39.61, for a total value of $3,954,187.08. Following the completion of the sale, the chief financial officer now owns 66,337 shares in the company, valued at $2,627,608.57. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
April 5, 2024 | marketbeat.com
Guggenheim Reiterates Buy Rating for Vera Therapeutics (NASDAQ:VERA)
Guggenheim reiterated a "buy" rating and set a $56.00 price objective on shares of Vera Therapeutics in a research note on Friday.
April 3, 2024 | marketbeat.com
Vera Therapeutics (NASDAQ:VERA) Shares Down 5.9%
Vera Therapeutics (NASDAQ:VERA) Shares Down 5.9%
April 3, 2024 | seekingalpha.com
Vera Therapeutics: Waiting For A Pullback
March 29, 2024 | marketbeat.com
Wellington Management Group LLP Takes $1.16 Million Position in Vera Therapeutics, Inc. (NASDAQ:VERA)
Wellington Management Group LLP bought a new position in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 84,506 shares of the company's stock, valued at
March 27, 2024 | marketbeat.com
Guggenheim Raises Vera Therapeutics (NASDAQ:VERA) Price Target to $56.00
Guggenheim boosted their target price on Vera Therapeutics from $27.00 to $56.00 and gave the stock a "buy" rating in a research report on Wednesday.
March 26, 2024 | finanznachrichten.de
Protagonist Therapeutics, Inc.: Protagonist Therapeutics Provides Update on VERIFY Patient Enrollment and Timing of Top-line Data
March 26, 2024 | insidertrades.com
Insider Selling: Vera Therapeutics, Inc. (NASDAQ:VERA) Director Sells 340,000 Shares of Stock
March 26, 2024 | insidertrades.com
Vera Therapeutics, Inc. (NASDAQ:VERA) Director Maha Katabi Sells 81,009 Shares
March 21, 2024 | marketbeat.com
Vera Therapeutics (NASDAQ:VERA) Trading Down 7%
Vera Therapeutics (NASDAQ:VERA) Stock Price Down 7%
March 21, 2024 | marketbeat.com
Vera Therapeutics (NASDAQ:VERA) PT Raised to $34.00
Wedbush boosted their price target on Vera Therapeutics from $21.00 to $34.00 and gave the stock a "neutral" rating in a research report on Thursday.
March 20, 2024 | markets.businessinsider.com
Buy Rating Affirmed on Vera Therapeutics Ahead of Key Atacicept Clinical Milestones
March 20, 2024 | markets.businessinsider.com
Buy Rating Affirmed for Vera Therapeutics with Promising Trials and Strong Financial Runway
March 20, 2024 | benzinga.com
Vera Therapeutics: Q4 Earnings Insights
March 20, 2024 | msn.com
Vera Therapeutics GAAP EPS of -$2.25 misses by $0.07
March 20, 2024 | investorplace.com
VERA Stock Earnings: Vera Therapeutics Misses EPS for Q4 2023
March 20, 2024 | globenewswire.com
Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
March 20, 2024 | marketbeat.com
Citigroup Inc. Buys 47,322 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA)
Citigroup Inc. lifted its stake in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 470.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 57,390 shares of the company's stock after purchasing an
March 17, 2024 | bbc.co.uk
Weekend Woman’s Hour: Irish folk singer Cara Dillon, The Hampstead Paedophile Hoax, Maximalism
March 16, 2024 | finance.yahoo.com
VERA Mar 2024 17.500 call
March 16, 2024 | ca.finance.yahoo.com
VERA Apr 2024 40.000 call
March 16, 2024 | finance.yahoo.com
VERA Apr 2024 50.000 put
Get Vera Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERA and its competitors with MarketBeat's FREE daily newsletter.

Must-See: Elon’s New Invention is Absolutely Insane (Ad)

Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…

VERA Media Mentions By Week

VERA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VERA
News Sentiment
▼
1.13

0.42
▲
Average
Medical
News Sentiment

VERA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VERA Articles
This Week
▼
9

3
▲
VERA Articles
Average Week

Get Vera Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:VERA) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Urgent Nvidia Warning
Altimetry
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
"The Biggest Drug Ever" Is Coming
Behind the Markets
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Elon’s New Device is About to Shock the World
InvestorPlace
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
Most important medical advance in 100 years
The Oxford Club